Wall Street Journal Rips Vaccine Makers: ‘Designed Studies to Get the Results They Wanted’

Wall Street Journal (WSJ) editorial board member Allysia Finley took to task both the federal government and the pharmaceutical giants profiting from the sale of their COVID mRNA booster shots for a “deceptive advertising” push for Americans to continue taking boosters without proof of their safety or effectiveness. The U.S. Department of Health and Human Services (HHS) and its health and regulatory agencies are engaged in a “deceptive advertising” campaign, wrote Finley Sunday, suggesting the pressure tactics “shouldn’t come as a surprise,” since the federal government “took the unprecedented step of ordering vaccine makers to produce them and recommending them without data supporting their safety or efficacy.”

Read More

Pfizer and Moderna Conducting Studies to Assess Long-Term Impacts of Myocarditis

Nearly two years after their mRNA “vaccines” were released to the public, both Pfizer and Moderna are finally conducting clinical trials to track long-term adverse health effects following a diagnosis of vaccine-associated myocarditis and pericarditis in teens and young adults under the age of 21. Myocarditis  can cause permanent damage to heart muscle and even death.

Read More

Moderna Suing Pfizer for COVID-19 Vaccine Patent Infringement

Moderna is filing patent infringement lawsuits against Pfizer and BioNTech in U.S. district court and German regional court Friday in connection with the two companies’ COVID-19 vaccine, Moderna announced.

Moderna alleges Pfizer and BioNTech’s Comirnaty vaccine breaches its mRNA technology patents submitted between 2010 and 2016. It claims they developed their vaccine by copying the technology Moderna used to make its mRNA COVID-19 vaccine, Spikevax.

Read More

Ivy League Study: Boosters, COVID-19 ‘Rebounds’ Fuel Skepticism of Federal Narratives

As the nation’s most powerful and twice-boosted infectious disease doctor battles a COVID-19 “rebound” two weeks after testing positive, new research from the public health schools at Harvard and Yale suggests the boosted fared worse against the first Omicron subvariant than the non-boosted.

The FDA is so alarmed by the “waning effectiveness” of boosters, whose formulation is still based on the ancestral Wuhan strain, that it asked manufacturers Thursday to add a “spike protein component” from the fourth and fifth Omicron subvariants to this fall’s boosters.

Read More

FDA Quickly Authorizes COVID Shots for Infants and Young Children

The Food and Drug Administration (FDA) quickly authorized the Moderna and Pfizer-BioNTech COVID vaccine shots for infants and young children Friday, paving the way for the Centers for Disease Control and Prevention (CDC) advisory committee to vote on authorization over the weekend to allow the youngest children to get the shots as early as next week.

Per the press announcement by the FDA, the Emergency Use Authorization (EUA) for the Moderna COVID vaccine for older children and adults has been “amended” to “include use of the vaccine in individuals 6 months through 17 years of age,” while the EUA for the Pfizer COVID shot will now include use of the vaccine for babies as young as “6 months through 4 years of age.”

Read More

NIH Study: Vaccinated People Develop Fewer Antibodies Than Unvaccinated After COVID Infection

Unvaccinated people develop much broader antibody immunity after being infected with COVID than people who have received the mRNA shots do, according to an NIH study. And the gap was large whether subjects had mild, moderate, or severe COVID infections.

The results of the study, which were highlighted by Alex Berenson on his Unreported Truths Substack, Daniel Horowitz at the Blaze, and Igor Chudov on his Substack newsletter, completely destroy the regime narrative that the shots provide stronger immunity than a natural infection, and may help explain why so many vaccinated Americans are now suffering from multiple COVID infections.

Read More

Moderna Recalls More than 750,000 COVID-19 Vaccine Doses After ‘Foreign Body’ Found in Lot

The pharmaceutical company Moderna on Friday recalled 764,900 doses of its Spikevax COVID-19 vaccine after a “foreign body” was found in a vial.

The contaminated lot was manufactured at a contract manufacturing site, ROVI, in Spain, and was distributed in mid-January 2022 in Norway, Poland, Portugal, Sweden and Spain, according to a company press release.

Read More

CDC Shortens Isolation Window for Positive COVID-19 Result to Five Days

The Centers for Disease Control and Prevention has updated the amount of time it recommends people isolate themselves after testing positive for COVID-19, shortening it from 10 days to five.

“Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others,” the CDC said in a statement Monday.

The CDC changed the guidance because officials believe the data indicates the majority of COVID-19 transmission takes place early in the course of the illness, “generally in the 1-2 days prior to onset of symptoms and the 2-3 days after,” the statement said.

Read More

Version of Pfizer Vaccine that Predates FDA Approval Still Being Distributed in Pennsylvania

healthcare worker giving vaccination

Of the three companies producing COVID vaccines in the U.S., only one—Pfizer Inc.—has yet gained full FDA approval, and at least some Pfizer vaccines currently being administered in Pennsylvania come from inventory that predates that approval.

On Aug. 23, the U.S. Food and Drug Administration (FDA) approved a Pfizer shot to prevent severe COVID-19 cases. Like Johnson & Johnson and Moderna, Pfizer had been a manufacturing vaccine to fight the coronavirus under federal emergency-use authorization (EUA). The injection produced by Pfizer under EUA is known as Pfizer BioNTech and the company’s post-FDA approval vaccine is called Comirnaty (pronounced kuh-MUR-nit-ee).

Read More

FDA Approves Moderna and Pfizer Boosters for Adults

The Food and Drug Administration (FDA) approved Moderna and Pfizer’s COVID-19 vaccines for booster shot use for adults in the U.S., the agency announced Friday,

The announcement was made just two months after the FDA first rejected the White House’s plan to administer booster shots to all adults the week of Sept. 20. FDA Acting Commissioner Janet Woodcock approved the booster without holding the usual public meeting to review the data, and the Centers for Disease Control and Prevention (CDC) will meet Friday afternoon to discuss the authorization, according to the FDA press release.

“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Woodcock said in the press release.

Read More